Garima Singhal
Impact in
-
- Medicinal Plants and Neuroprotection
- Drug Discovery top 10%
Papers in
-
- Fibroblast Growth Factor Research 7
- Epigenetics and DNA Methylation 3
- PI3K/AKT/mTOR signaling in cancer 2
- Oncology 4
- Co-authors
- Riju Bhavesh (2 shared papers)Rajendra Pal Singh (2 shared papers)Ashish Ranjan Sharma (2 shared papers)Eleftheria Maratos–Flier (7 shared papers)Jeffrey S. Flier (5 shared papers)Ffolliott M. Fisher (5 shared papers)Andrew C. Adams (3 shared papers)Chiara Macchi (1 shared paper)
- Journals
- Molecular Metabolism (3 papers)Talanta (2 papers)PLoS ONE (2 papers)Metabolism (1 paper)DNA and Cell Biology (1 paper)
- Partner nations
- United StatesIndiaItaly
In The Last Decade
Garima Singhal
22 papers receiving 1.4k citations
Garima Singhal's Hit Papers
Peers
Comparison fields: 5 of 113
- Complementary and alternative medicine 126
- Drug Discovery 2
- Materials Chemistry 550
- Endocrinology, Diabetes and Metabolism 141
- Molecular Biology 494
Countries citing papers authored by Garima Singhal
This map shows the geographic impact of Garima Singhal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garima Singhal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garima Singhal more than expected).
Fields of papers citing papers by Garima Singhal
This network shows the impact of papers produced by Garima Singhal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garima Singhal. The network helps show where Garima Singhal may publish in the future.
Co-authors
The 25 scholars most cited alongside Garima Singhal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Biosynthesis of silver nanoparticles using Ocimum sanctum (Tulsi) leaf extract and screening its antimicrobial activity Hit paper breakdown → | 2011 | 619 |
| 2 | 2019 | 188 | |
| 3 | 2017 | 123 | |
| 4 | 2016 | 103 | |
| 5 | 2011 | 76 | |
| 6 | 2008 | 70 | |
| 7 | 2018 | 63 | |
| 8 | 2019 | 31 | |
| 9 | 2016 | 29 | |
| 10 | 2016 | 28 | |
| 11 | 2011 | 21 | |
| 12 | 2012 | 19 | |
| 13 | 2009 | 14 | |
| 14 | 2021 | 9 | |
| 15 | 1967 | 8 | |
| 16 | 2009 | 7 | |
| 17 | 2008 | 6 | |
| 18 | 2024 | 3 | |
| 19 | 2020 | 3 | |
| 20 | 2022 | 3 |
About Garima Singhal
Garima Singhal is a scholar working on Molecular Biology, Oncology, Pharmacology, Computer Vision and Pattern Recognition and Artificial Intelligence, having authored 24 papers that have together received 1.4k indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (7 papers), Pharmacogenetics and Drug Metabolism (3 papers), Epigenetics and DNA Methylation (3 papers), Liver physiology and pathology (2 papers), Nanoparticles: synthesis and applications (2 papers), Computational Drug Discovery Methods (2 papers), Phagocytosis and Immune Regulation (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Complementary and alternative medicine (126 citations), Drug Discovery (2 citations), Materials Chemistry (550 citations), Endocrinology, Diabetes and Metabolism (141 citations) and Molecular Biology (494 citations). Garima Singhal has collaborated with scholars based in United States, India and Italy. Frequent co-authors include Riju Bhavesh, Rajendra Pal Singh, Ashish Ranjan Sharma, Eleftheria Maratos–Flier, Jeffrey S. Flier, Ffolliott M. Fisher, Andrew C. Adams, Chiara Macchi, Jonathan M. Dreyfuss and Soravis Osataphan. Their work appears in journals such as Molecular Metabolism, Talanta, PLoS ONE, Metabolism and DNA and Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.